Met Life Investment Management, LLC Novavax Inc Transaction History

Met Life Investment Management, LLC

  • $18.1 Billion
  • Q1 2025

A detailed history of Met Life Investment Management, LLC transactions in Novavax Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 89,032 shares of NVAX stock, worth $588,501. This represents 0.0% of its overall portfolio holdings.

Number of Shares
89,032
Previous 93,447 4.72%
Holding current value
$588,501
Previous $751,000 24.1%
% of portfolio
0.0%
Previous 0.0%

Shares

42 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
SELL
$6.41 - $10.82 $28,300 - $47,770
-4,415 Reduced 4.72%
89,032 $570,000
Q4 2024

Feb 13, 2025
BUY
$7.22 - $14.68 $84,654 - $172,123
11,725 Added 14.35%
93,447 $751,000
Q2 2024

Aug 13, 2024
BUY
$3.89 - $20.97 $90,345 - $487,028
23,225 Added 39.7%
81,722 $1.03 Million
Q1 2024

May 14, 2024
BUY
$3.76 - $6.02 $219,948 - $352,151
58,497 New
58,497 $279,000
Q3 2023

May 09, 2024
BUY
$6.81 - $9.74 $277,956 - $397,547
40,816 Added 784.62%
46,018 $333,000
Q2 2023

Apr 29, 2024
BUY
$6.67 - $9.52 $306,940 - $438,091
46,018 New
46,018 $341,000
Q2 2023

Aug 10, 2023
BUY
$6.67 - $9.52 $272,242 - $388,568
40,816 Added 784.62%
46,018 $341,000
Q1 2023

May 09, 2024
BUY
$5.76 - $12.48 $29,963 - $64,920
5,202 New
5,202 $36.1 Million
Q1 2023

May 15, 2023
BUY
$5.76 - $12.48 $2,793 - $6,052
485 Added 10.28%
5,202 $36,000
Q4 2022

May 10, 2024
SELL
$8.86 - $25.04 $1,098 - $3,104
-124 Reduced 2.56%
4,717 $48,000
Q4 2022

Jun 14, 2023
SELL
$8.86 - $25.04 $4,297 - $12,144
-485 Reduced 9.32%
4,717 $48,000
Q4 2022

Mar 22, 2023
SELL
$8.86 - $25.04 $1,098 - $3,104
-124 Reduced 2.56%
4,717 $48,000
Q4 2022

Feb 15, 2023
SELL
$8.86 - $25.04 $1,098 - $3,104
-124 Reduced 2.56%
4,717 $48,000
Q3 2022

May 10, 2024
BUY
$18.2 - $76.12 $54 - $228
3 Added 0.06%
4,841 $88,000
Q3 2022

Jun 14, 2023
SELL
$18.2 - $76.12 $6,570 - $27,479
-361 Reduced 6.94%
4,841 $88,000
Q3 2022

Mar 22, 2023
BUY
$18.2 - $76.12 $54 - $228
3 Added 0.06%
4,841 $88,000
Q3 2022

Nov 14, 2022
BUY
$18.2 - $76.12 $54 - $228
3 Added 0.06%
4,841 $88,000
Q2 2022

May 10, 2024
SELL
$36.28 - $75.29 $1,414 - $2,936
-39 Reduced 0.8%
4,838 $248,000
Q2 2022

Jun 20, 2023
SELL
$36.28 - $75.29 $13,205 - $27,405
-364 Reduced 7.0%
4,838 $248,000
Q2 2022

Mar 22, 2023
SELL
$36.28 - $75.29 $1,414 - $2,936
-39 Reduced 0.8%
4,838 $248,000
Q2 2022

Aug 11, 2022
SELL
$36.28 - $75.29 $1,414 - $2,936
-39 Reduced 0.8%
4,838 $249,000
Q1 2022

May 10, 2024
BUY
$69.73 - $142.9 $340,073 - $696,923
4,877 New
4,877 $359,000
Q1 2022

Jun 20, 2023
SELL
$69.73 - $142.9 $22,662 - $46,442
-325 Reduced 6.25%
4,877 $359,000
Q1 2022

Mar 22, 2023
SELL
$69.73 - $142.9 $1.24 Million - $2.53 Million
-17,715 Reduced 78.41%
4,877 $359,000
Q1 2022

May 12, 2022
BUY
$69.73 - $142.9 $340,073 - $696,923
4,877 New
4,877 $359,000
Q2 2021

Aug 16, 2021
SELL
$121.0 - $257.67 $2.73 Million - $5.82 Million
-22,592 Closed
0 $0
Q1 2021

May 17, 2024
SELL
$112.98 - $319.93 $4.06 Million - $11.5 Million
-35,905 Reduced 61.38%
22,592 $4.1 Million
Q1 2021

Jun 26, 2023
BUY
$112.98 - $319.93 $1.96 Million - $5.56 Million
17,390 Added 334.29%
22,592 $4.1 Billion
Q1 2021

Mar 22, 2023
SELL
$112.98 - $319.93 $220,762 - $625,143
-1,954 Reduced 7.96%
22,592 $4.1 Million
Q1 2021

May 14, 2021
SELL
$112.98 - $319.93 $220,762 - $625,143
-1,954 Reduced 7.96%
22,592 $4.1 Million
Q4 2020

May 24, 2024
SELL
$78.74 - $139.5 $84,802 - $150,241
-1,077 Reduced 4.2%
24,546 $2.74 Million
Q4 2020

Jun 22, 2023
BUY
$78.74 - $139.5 $1.52 Million - $2.7 Million
19,344 Added 371.86%
24,546 $2.74 Million
Q4 2020

Mar 22, 2023
SELL
$78.74 - $139.5 $84,802 - $150,241
-1,077 Reduced 4.2%
24,546 $2.74 Million
Q4 2020

Feb 16, 2021
SELL
$78.74 - $139.5 $84,802 - $150,241
-1,077 Reduced 4.2%
24,546 $2.74 Million
Q3 2020

Jun 26, 2023
BUY
$79.44 - $178.51 $1.62 Million - $3.65 Million
20,421 Added 392.56%
25,623 $2.78 Million
Q2 2020

May 24, 2024
SELL
$13.86 - $83.61 $455,633 - $2.75 Million
-32,874 Reduced 56.2%
25,623 $2.14 Billion
Q2 2020

Jun 26, 2023
BUY
$13.86 - $83.61 $283,035 - $1.71 Million
20,421 Added 392.56%
25,623 $2.14 Million
Q2 2020

Mar 22, 2023
BUY
$13.86 - $83.61 $150,076 - $905,329
10,828 Added 73.19%
25,623 $2.14 Million
Q2 2020

Aug 14, 2020
BUY
$13.86 - $83.61 $150,076 - $905,329
10,828 Added 73.19%
25,623 $2.14 Million
Q1 2020

Jul 12, 2023
BUY
$3.93 - $16.0 $37,700 - $153,488
9,593 Added 184.41%
14,795 $200,000
Q1 2020

Mar 22, 2023
BUY
$3.93 - $16.0 $39,606 - $161,248
10,078 Added 213.65%
14,795 $200,000
Q1 2020

May 15, 2020
BUY
$3.93 - $16.0 $58,144 - $236,720
14,795 New
14,795 $201,000

Others Institutions Holding NVAX

# of Institutions
300
Shares Held
90M
Call Options Held
5.76M
Put Options Held
6.65M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $517M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email